Pharma on Tenu Tech Brief https://cluster-site.onrender.com/tags/pharma/ Recent content in Pharma on Tenu Tech Brief Hugo -- 0.146.0 en-us Tue, 24 Feb 2026 06:03:48 +0000 Biotech Startup M&A Is Reliably Delivering Some Big Exits https://cluster-site.onrender.com/posts/biotech-startup-ma-is-reliably-delivering-some-big-exits/ Wed, 18 Feb 2026 12:00:33 +0000 https://cluster-site.onrender.com/posts/biotech-startup-ma-is-reliably-delivering-some-big-exits/ • Over past two years, biotech M&A exceeded $38B, surpassing many historic tech exits. • 2026 kickoff: Eli Lilly to pay up to $2.4B for Orna Therapeutics, boosting in‑vivo cell the Rhododendron-derived drugs now made by bacteria https://cluster-site.onrender.com/posts/rhododendron-derived-drugs-now-made-by-bacteria/ Tue, 17 Feb 2026 22:50:05 +0000 https://cluster-site.onrender.com/posts/rhododendron-derived-drugs-now-made-by-bacteria/ • E. coli engineered to synthesize rhododendron-derived compounds with anticancer, anti-HIV, antidiabetic, anti-inflammatory properties. • Kobe University’s rational design strateg COO of Mayo Clinic Platform Believes De-identified Data Leads to Loss of Utility for Pharma, Other Third Parties https://cluster-site.onrender.com/posts/coo-of-mayo-clinic-platform-believes-de-identified-data-leads-to-loss-of-utility-for-pharma-other-third-parties/ Fri, 13 Feb 2026 02:28:51 +0000 https://cluster-site.onrender.com/posts/coo-of-mayo-clinic-platform-believes-de-identified-data-leads-to-loss-of-utility-for-pharma-other-third-parties/ • COO Maneesh Goyal argues de-identified data still risks re-identification with advanced compute. • Mayo Clinic Platform’s Orchestrate platform offers pharma/medtech access to ric WHO renews commitment to a leprosy-free world, spotlighting partnership and progress ahead of World Leprosy Day https://cluster-site.onrender.com/posts/who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day/ Wed, 21 Jan 2026 17:14:46 +0000 https://cluster-site.onrender.com/posts/who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day/ • WHO reaffirms leprosy elimination goal, highlighting partnership with Novartis. • 172,717 new cases reported worldwide in 2024, yet 55 regions zero cases. • Multidrug therapy (MD Treatment of a teenager with an ultra-rare condition is a medical milestone https://cluster-site.onrender.com/posts/treatment-of-a-teenager-with-an-ultra-rare-condition-is-a-medical-milestone/ Mon, 19 Jan 2026 14:49:36 +0000 https://cluster-site.onrender.com/posts/treatment-of-a-teenager-with-an-ultra-rare-condition-is-a-medical-milestone/ • First FDA‑approved therapy for a rare pediatric disease, offering hope to thousands of families. • The drug, developed by a biotech startup, uses gene editing to correct a single